Experimental models and the role of RNA in immunotherapy of leukemia.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003851:Deoxyribonucleases / Q000494:pharmacology; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007111:Immunity, Cellular; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D051379:Mice; D010537:Peritoneum / Q000276:immunology; D011379:Prognosis; D012313:RNA / Q000302:isolation & purification / Q000627:therapeutic use*; D012260:Ribonucleases / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D013864:Thioglycolates / Q000494:pharmacology
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D013864:Thioglycolates; D012313:RNA; D003851:Deoxyribonucleases; D012260:Ribonucleases